(Q53000020)

10 May 2018

title

Scale of interest versus scale of estimation: comparing alternative estimators for the incremental costs of a comorbidity. (English)

1 reference

10 May 2018

1 reference

Anirban Basu

1

1 reference

10 May 2018

Bhakti V Arondekar

series ordinal

2

1 reference

10 May 2018

Paul J Rathouz

series ordinal

3

1 reference

10 May 2018

language of work or name

English

0 references

publication date

1 October 2006

1 reference

10 May 2018

published in

Health Economics

1 reference

10 May 2018

volume

15

1 reference

10 May 2018

issue

10

1 reference

10 May 2018

page(s)

1091-1107

1 reference

10 May 2018

Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial

cites work

1 reference

An iconoclastic view of health cost containment

21 January 2018

1 reference

7 January 2021

Estimating log models: to transform or not to transform?

1 reference

7 January 2021

Modeling risk using generalized linear models

1 reference

7 January 2021

Costs of lower-extremity ulcers among patients with diabetes

1 reference

7 January 2021

1 reference

7 January 2021

Direct medical costs attributable to acute myocardial infarction and ischemic stroke in cohorts with atherosclerotic conditions

1 reference

7 January 2021

Estimating marginal and incremental effects on health outcomes using flexible link and variance function models

1 reference

7 January 2021

Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994.

1 reference

7 January 2021

The Effect of the Angiotensin-Converting–Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial Infarction

1 reference

7 January 2021

Death rates from coronary disease--progress and a puzzling paradox

1 reference

7 January 2021

Prediction of 6 months left ventricular dilatation after myocardial infarction in relation to cardiac morbidity and mortality. Application of a new dilatation model to GISSI-3 data

1 reference

7 January 2021

Prognosis after initial myocardial infarction: The Framingham study

1 reference

7 January 2021

Patterns of left ventricular dilation during the six months after myocardial infarction

1 reference

7 January 2021

Prognosis after recovery from acute myocardial infarction

1 reference

7 January 2021

Interrelation of left ventricular ejection fraction, pulmonary congestion and outcome in acute myocardial infarction

1 reference

7 January 2021

Accounting for future costs in medical cost-effectiveness analysis

1 reference

7 January 2021

Clinical correlates of in-hospital costs for acute myocardial infarction in patients 65 years of age and older

1 reference

7 January 2021

Preoperative prediction of postoperative morbidity in coronary artery bypass grafting

1 reference

7 January 2021

Comorbidity measures for use with administrative data

1 reference

7 January 2021

Comparison of the performance of two comorbidity measures, with and without information from prior hospitalizations.

1 reference

7 January 2021

Generalized Linear Models

1 reference

7 January 2021

Smearing Estimate: A Nonparametric Retransformation Method

1 reference

7 January 2021

The logged dependent variable, heteroscedasticity, and the retransformation problem.

1 reference

7 January 2021

Much ado about two: reconsidering retransformation and the two-part model in health econometrics.

1 reference

7 January 2021

Comparing alternative models: log vs Cox proportional hazard?

1 reference

7 January 2021

Estimation with Heteroscedastic Error Terms

1 reference

7 January 2021

Linear regression analysis of censored medical costs

1 reference

7 January 2021

A regression-based method for estimating mean treatment cost in the presence of right-censoring

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEC.1099

1 reference

10 May 2018

1 reference

10 May 2018